Non-promotional post on behalf of Gilead Sciences Ltd.

Non-promotional post on behalf of Gilead Sciences Ltd.

The Gilead UK & Ireland Oncology Fellowship and Medical Grants Programme accepts applications for any project that supports innovation and best practice sharing with the aim to improve care and reduce inequalities in accessing healthcare in the field of oncology. Priority will be given to projects focussing on breast cancer.

Funding can be used to support a variety of projects including, but not limited to:

  • Audits or registry reviews assessing patient profiles, disease outcomes and treatment patterns (but not efficacy of specific treatments)
  • Setting up new infrastructure for better diagnosis or detection of disease, or prediction or monitoring of safety and efficacy outcomes to treatment including increased disease awareness in primary care and amongst members of the public
  • Establishing novel patient support programmes or tools
  • New protocols to facilitate improved efficiency in patient care pathways
  • Frameworks to improve monitoring of patient-reported outcome measures or quality of life instruments or educational tools for patients and carers

Applicants with a project that falls outside of this scope but will add clinical value or will investigate an area of unmet need in the field of oncology may still apply. All applications will be appraised based on their individual merit and focus on driving positive change in patient care.

The application window will close on 31st July 2026. More details about the Programme in oncology can be found in the attached flyer.

Application support

Details on the application process and project eligibility are available on the Gilead UK and Ireland website.

Gilead is holding an Oncology Webinar on the 12 June, which will include presentations from previous awardees on their projects, implementation approaches, and their impact on oncology patient care, along with an overview of the Oncology GFP and a live Q&A round. You can sign up here.

Applicants are advised to review all information on the Apply Now page before starting an application, including the eligibility criteria, FAQs and user guidance. Applicants should also ensure that the correct tags are used on the application portal so that applications are directed to the appropriate team.

Any questions regarding the process or the application form may be directed to [email protected].

Date of preparation: May 2026

Code: UKI-UNB-2418 v2.0

Latest News

By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article
By Suriya Marshall on 27th September 2026

Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation”

Session Title: Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation” When: 12th October 2026. From 1-2pm Online event  Session Outline: This presentation explores the role of cancer vaccines in transforming cancer…

Read article
By BOPA on 8th September 2026

Register now: Immunotherapy: Beyond Checkpoint Inhibitors

Immunotherapy: Beyond Checkpoint Inhibitors WHEN: Tuesday 17th November 2026 WHERE:  Wellcome Collection, 183 Euston Road, London, NW1 BE COST: A non-refundable payment of £25.00. We are pleased to announce registration is now available for…

Read article